Tags

Type your tag names separated by a space and hit enter

The medicinal use of cannabis and cannabinoids--an international cross-sectional survey on administration forms.
J Psychoactive Drugs 2013 Jul-Aug; 45(3):199-210JP

Abstract

Cannabinoids, including tetrahydrocannabinol and cannabidiol, are the most important active constituents of the cannabis plant. Over recent years, cannabinoid-based medicines (CBMs) have become increasingly available to patients in many countries, both as pharmaceutical products and as herbal cannabis (marijuana). While there seems to be a demand for multiple cannabinoid-based therapeutic products, specifically for symptomatic amelioration in chronic diseases, therapeutic effects of different CBMs have only been directly compared in a few clinical studies. The survey presented here was performed by the International Association for Cannabinoid Medicines (IACM), and is meant to contribute to the understanding of cannabinoid-based medicine by asking patients who used cannabis or cannabinoids detailed questions about their experiences with different methods of intake. The survey was completed by 953 participants from 31 countries, making this the largest international survey on a wide variety of users of cannabinoid-based medicine performed so far. In general, herbal non-pharmaceutical CBMs received higher appreciation scores by participants than pharmaceutical products containing cannabinoids. However, the number of patients who reported experience with pharmaceutical products was low, limiting conclusions on preferences. Nevertheless, the reported data may be useful for further development of safe and effective medications based on cannabis and single cannabinoids.

Authors+Show Affiliations

Bedrocan BV, The Netherlands. ahazekamp@bedrocan.nlNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

24175484

Citation

Hazekamp, Arno, et al. "The Medicinal Use of Cannabis and Cannabinoids--an International Cross-sectional Survey On Administration Forms." Journal of Psychoactive Drugs, vol. 45, no. 3, 2013, pp. 199-210.
Hazekamp A, Ware MA, Muller-Vahl KR, et al. The medicinal use of cannabis and cannabinoids--an international cross-sectional survey on administration forms. J Psychoactive Drugs. 2013;45(3):199-210.
Hazekamp, A., Ware, M. A., Muller-Vahl, K. R., Abrams, D., & Grotenhermen, F. (2013). The medicinal use of cannabis and cannabinoids--an international cross-sectional survey on administration forms. Journal of Psychoactive Drugs, 45(3), pp. 199-210.
Hazekamp A, et al. The Medicinal Use of Cannabis and Cannabinoids--an International Cross-sectional Survey On Administration Forms. J Psychoactive Drugs. 2013;45(3):199-210. PubMed PMID: 24175484.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The medicinal use of cannabis and cannabinoids--an international cross-sectional survey on administration forms. AU - Hazekamp,Arno, AU - Ware,Mark A, AU - Muller-Vahl,Kirsten R, AU - Abrams,Donald, AU - Grotenhermen,Franjo, PY - 2013/11/2/entrez PY - 2013/11/2/pubmed PY - 2013/11/15/medline SP - 199 EP - 210 JF - Journal of psychoactive drugs JO - J Psychoactive Drugs VL - 45 IS - 3 N2 - Cannabinoids, including tetrahydrocannabinol and cannabidiol, are the most important active constituents of the cannabis plant. Over recent years, cannabinoid-based medicines (CBMs) have become increasingly available to patients in many countries, both as pharmaceutical products and as herbal cannabis (marijuana). While there seems to be a demand for multiple cannabinoid-based therapeutic products, specifically for symptomatic amelioration in chronic diseases, therapeutic effects of different CBMs have only been directly compared in a few clinical studies. The survey presented here was performed by the International Association for Cannabinoid Medicines (IACM), and is meant to contribute to the understanding of cannabinoid-based medicine by asking patients who used cannabis or cannabinoids detailed questions about their experiences with different methods of intake. The survey was completed by 953 participants from 31 countries, making this the largest international survey on a wide variety of users of cannabinoid-based medicine performed so far. In general, herbal non-pharmaceutical CBMs received higher appreciation scores by participants than pharmaceutical products containing cannabinoids. However, the number of patients who reported experience with pharmaceutical products was low, limiting conclusions on preferences. Nevertheless, the reported data may be useful for further development of safe and effective medications based on cannabis and single cannabinoids. SN - 0279-1072 UR - https://www.unboundmedicine.com/medline/citation/24175484/The_medicinal_use_of_cannabis_and_cannabinoids L2 - http://www.tandfonline.com/doi/full/10.1080/02791072.2013.805976 DB - PRIME DP - Unbound Medicine ER -